ENSC: Ensysce Biosciences, Inc. Stock

by  •  • Comments Off on ENSC: Ensysce Biosciences, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 4.43
Enterprise Value ($M) 4.69
Book Value ($M) -0.65
Book Value / Share -0.09
Price / Book -6.80
NCAV ($M) -1.07
NCAV / Share -0.14
Price / NCAV -4.14

Profitability (mra)
Return on Invested Capital (ROIC) -10.00
Return on Assets (ROA) -2.71
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 0.69
Current Ratio 0.69

Balance Sheet (mrq) ($M)
Current Assets 2.29
Assets 2.71
Liabilities 3.36
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 2.23
Operating Income -10.72
Net Income -10.61
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -10.78
Cash from Investing 0.00
Cash from Financing 8.76

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G/A Lincoln Park Capital Fund, LLC 3.79 -91.74
07-18 13D/A Gower Bob G 5.70 0.00

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-15 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-K
2023-11-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2023-08-11 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2023-05-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-26 36,336 9,000 403.73
2024-04-25 23,709 3,737 634.44
2024-04-24 2,865 2,806 102.10
2024-04-23 6,521 6,291 103.66

(click for more detail)

Similar Companies
ELDN – Eledon Pharmaceuticals, Inc. ELUT – Elutia Inc.
ENLV – Enlivex Therapeutics Ltd. ENTX – Entera Bio Ltd.
ENVB – Enveric Biosciences, Inc.


Financial data and stock pages provided by
Fintel.io